Evidence strategy can’t wait for launch. Connect science to commercial outcomes from day one.
Medical Affairs teams are under more pressure than ever — expected to shape evidence strategy well before launch, engage increasingly complex stakeholder landscapes, and demonstrate impact in terms that leadership and commercial partners understand.
To win, teams need to move faster, communicate more clearly, and connect science to commercial outcomes from day one. Most partners bring scientific depth or strategic capability. We bring both.
Our scientist-strategists work across therapeutic areas to build scientific platforms that are rigorous enough to earn credibility and clear enough to drive action — from evidence generation and medical publications to KOL engagement and field medical strategy.
Across 200+ product launches and 40+ therapeutic areas, we have cultivated long-term partnerships with global pharma and biotech organizations built on scientific credibility and outcomes that last.
End-to-end scientific strategy, from evidence generation to execution
Scientific strategy is most effective when every piece is connected, from building the evidence base and engaging the right stakeholders to communicating the science in ways that earn credibility and drive action.
Scientific & Evidence Foundations
Conducting targeted and systematic literature reviews, developing disease state dossiers, creating scientific platforms and lexicons, and designing core training materials and field resources that ensure teams and stakeholders start from a shared, credible understanding of the science.
Strategic Planning & Market Engagement
Supporting medical strategy and tactical planning, KOL identification and engagement, advisory boards, Delphi panels, patient advocacy, and integrated evidence generation planning in a way that’s aligned across functions and across the lifecycle.
Scientific Communication & Execution
Creating communication and publication strategies, abstracts, posters, congress planning, and educational summits that deliver the science in formats that build confidence and drive decisions.
Senior experts, in your corner
Integrated across the full lifecycle
Integrated expertise across medical strategy, publications, KOL engagement, and tactical planning — connected across functions, without compromising independence or compliance.
Pre-launch
Establish the foundation with a scientific platform, disease state dossier, stakeholder mapping, and early KOL engagement.
Pivotal data & Approval
Sharpen the narrative with publication strategy, advisory boards, congress coverage, and medical strategy alignment ahead of approval.
Launch & Beyond
Sustain credibility and adapt with real-world evidence generation, ongoing publications, KOL and patient advocacy, and annual strategic updates.
